Massachusetts General Hospital | Digestive Healthcare Center

Event Details

Thursday, October 15, 2009
5:00 pm to 7:00 pm

Sheraton Colonial Boston
One Audubon Road, Wakefield, MA 01880

About The Program This two hour, certified CME education program is offered by the Massachusetts General Hospital Digestive Healthcare Center and allows gastroenterologists and primary care physicians to rapidly acquire knowledge of recent advances in screening and treatment for Barrett's esophagus and other precursors to esophageal cancer.

Esophageal cancer is growing at an epidemic pace. According to the American Cancer Society, more than 16,000 new cases are diagnosed each year. And in 2008, the American College of Gastroenterology issued new guidelines for the diagnosis, surveillance, and treatment of Barrett’s esophagus in adults, spurred by advances over the past several years.

Tuition is only $40, and dinner will be included. Visit our registration website to secure your spot.

Time	Event
4:45	Registration
5:00	Dinner will be served beginning at 5:00 pm The New Epidemic of Esophageal Cancer, David Ryan, MD Recognize the reasons for the current epidemic of esophageal cancer Employ the general principles of staging and treatment of esophageal cancer
5:20	Who Needs Screening and Who Needs Treatment, Myles Keroack, MD Explain the management of a patient with GERD and Barrett’s esophagus Implement the guidelines on Barrett’s surveillance Utilize independent path review if indeterminate dysplasia is identified
5:40	Endoscopic Therapy for Barrett’s Ablation, David Forcione, MD Discuss the published results of ablative therapies for patients with Barrett’s esophagus and high grade dysplasia Evaluate existing technologies such as cryotherapy, photodynamic therapy, endoscopic mucosal resection (EMR) and radiofrequency ablation for Barrett’s mucosa
6:00	Optimal Control of Gastroesophageal Reflux, David Rattner, MD State the role of acid and non-acid reflux in symptom generation Evaluate indications for medical, endoscopic and surgical interventions to control GERD Evaluate patients with atypical symptoms of GERD
6:20	Minimally Invasive Treatment of Esophageal Cancer, Christopher Morse, MD Apply the evaluation and staging work up for patients who are candidates for surgical therapy Explain the basic techniques of minimally invasive esophageal resections Discuss the expected surgical and oncological outcomes
6:40	Case presentations
7:00	Adjourn

David W. Rattner, MD

Chief, Division of General and Gastrointestinal Surgery

Dr. Rattner received his medical degree from the Johns Hopkins School of Medicine. After completing his residency in surgery at Massachusetts General Hospital, he joined the active clinical faculty, where he is now Chief of the Division of General and Gastrointestinal Surgery. In addition to pursuing research on minimally invasive surgery and technology transfer, Dr. Rattner is a professor of Surgery at Harvard Medical School. He has published over 150 original articles concerning pancreatic disease and biliary disease, gastroesophageal reflux disease and minimally invasive therapy.

David G. Forcione, MD

Dr. Forcione received his medical degree from the Boston University School of Medicine and completed his residency and fellowship at Massachusetts General Hospital. He is also an instructor in Medicine at Harvard Medical School.

Myles D. Keroack, MD

After receiving his medical degree from Tufts University School of Medicine, Dr. Keroack completed his residency at University of Massachusetts Medical Center. His clinical interests center on Therapeutic Endoscopy and Video Capsule Endoscopy.

Christopher R. Morse, MD

Dr. Morse received his medical degree from Columbia University's College of Physicians and Surgeons. He has ongoing clinical research projects in minimally invasive esophageal surgery and has presented, published and written several chapters on esophageal and thoracic surgery.

David P. Ryan, MD

The principal focus of Dr. Ryan's clinical research is the design and implementation of phases I and II trials in gastrointestinal malignancies, and he has published over 50 articles in peer-reviewed journals, reviews, book chapters, and editorials and authored numerous abstracts.